US Patent Issued to RISE BIOPHARMACEUTICALS on Nov. 18 for "Pharmaceutical compositions and use thereof for relieving resistance due to cancer chemotherapy and enhancing effect of cancer chemotherapy" (Taiwanese Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,227, issued on Nov. 18, was assigned to RISE BIOPHARMACEUTICALS INC. (Beijing).

"Pharmaceutical compositions and use thereof for relieving resistance due to cancer chemotherapy and enhancing effect of cancer chemotherapy" was invented by Jya-Wei Cheng (Tainan, Taiwan), Hsi-Tsung Cheng (Tainan, Taiwan), Hui-Yuan Yu (Tainan, Taiwan), Su-Ya Hsu (Tainan, Taiwan) and Wei-Chen Lee (Tainan, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel chemokine receptor antagonistic modified peptide. The novel chemokine receptor antagonistic modified peptide can be combined with a chemotherapeutic drug for treating cancer, es...